Treatment of disorders associated with inflammation

Patent metadata

Field	Value
Publication number	US-11446496-B2
Application number	US-201816955393-A
Country	US
Kind code	B2
Filing date	Dec 20, 2018
Priority date	Dec 20, 2017
Publication date	Sep 20, 2022
Grant date	Sep 20, 2022

Abstract

Stimulation of neural activity in a nerve supplying the spleen, wherein the nerve is adjacent to the splenic artery at a position where the splenic artery is not in direct contact with the pancreas, can modulate pro- and anti-inflammatory molecules levels, thereby reducing inflammation and providing ways of treating disorders, such as disorders associated with inflammation. The invention provides improved ways of reducing inflammation with minimized off-target effects, in particular surgical trauma.

First claim

The invention claimed is:

1. A system for stimulating neural activity of a splenic arterial nerve, the system comprising:
at least one electrode in signaling contact with the splenic arterial nerve at a site where a splenic artery is not in direct contact with a pancreas; and
at least one controller electrically coupled to the at least one electrode, the at least one controller configured to control operation of the at least one electrode to apply an electrical signal to the splenic arterial nerve, wherein a charge density per phase applied to the splenic arterial nerve by the electrical signal is between 70 μC to 1100 μC per cm2 per phase, wherein the electrical signal produces an improvement in a physiological parameter in a subject, and wherein the improvement in the physiological parameter is one or more of a group consisting of: a reduction in a pro-inflammatory cytokine, an increase in an anti-inflammatory cytokine, an increase in a catecholamine, a change in an immune cell population, a change in an immune cell surface co-stimulatory molecule, a reduction in a factor involved in an inflammation cascade, a change in a level of an immune response mediator, and a decrease in splenic blood flow.

2. The system of claim 1 , wherein the site is a position of the splenic artery separated from a surface of the pancreas by a distance in a range of from 0.5 cm to 4 cm.

3. The system of claim 1 , wherein the site is at a splenic arterial loop.

4. The system of claim 1 , wherein the electrical signal comprises a pulse train, the pulse train comprising a plurality of pulses.

5. The system of claim 4 , wherein the plurality of pulses are charge-balanced and biphasic.

6. The system of claim 1 , further comprising at least one detector configured to detect one or more of a group consisting of: systemic arterial blood pressure, blood flow rate in a spleen, blood flow rate in the splenic artery, blood flow rate in a splenic vein, spleen volume, splenic tissue perfusion, neural activity in the splenic arterial nerve, impedance of the at least one electrode, and stimulator voltage compliance.

7. The system of claim 6 , wherein the at least one controller is further configured to apply an electrical signal to the splenic arterial nerve for determining correct placement of a neural interface in signaling contact with the splenic arterial nerve prior to applying the electrical signal to the splenic arterial nerve, wherein the electrical signal has a frequency of ≤300 Hz and is applied continuously for a duration of ≤3 hours.

8. The system of claim 7 , wherein the at least one detector is further configured to detect spleen volume, and wherein the at least one controller is further configured to determine if a detected spleen volume is lower than a baseline spleen volume and, if so, to indicate to an operator that the neural interface has been placed in signaling contact with the splenic arterial nerve correctly.

9. The system of claim 8 , wherein the at least one detector is further configured to measure spleen volume using ultrasound.

10. The system of claim 6 , wherein the at least one detector is further configured to detect one or more of a group consisting of: systemic arterial blood pressure, blood flow rate in the spleen, blood flow rate in the splenic artery, and blood flow rate in the splenic vein, and wherein the at least one controller is further configured to determine if a detected blood flow is different than a baseline blood flow and, if so, to indicate to an operator that a neural interface has been placed in signaling contact with the splenic arterial nerve correctly.

11. The system of claim 10 , wherein the at least one detector is further configured to detect impedance of the at least one electrode, and wherein the at least one controller is further configured to determine if a detected impedance is different than baseline impedance and, if so, to indicate to an operator that the neural interface has been placed in signaling contact with the splenic arterial nerve correctly.

12. A method of reversibly stimulating neural activity in a nerve supplying a spleen, the method comprising:
providing the system of claim 1 ;
positioning the at least one electrode in signaling contact with the nerve adjacent to a splenic arterial loop; and
controlling the operation of the at least one electrode with at least one controller to apply an electrical signal to the nerve to stimulate neural activity, wherein the neural activity returns to a baseline level upon cessation of the electrical signal.

13. The method of claim 12 , wherein the method is for treating a disorder associated with inflammation in a subject.

Assignees

• Galvani Bioelectronics Ltd

Inventors

• Vervoordeldonk Margarita J
• Irwin Eric
• Chew Daniel John
• Donega Matteo
• Cleypool Cindy
• Gupta Isha

Classifications

• A61N1/36171

  Frequency · CPC title

• A61N1/36053

  adapted for vagal stimulation (A61N1/36114 takes precedence) · CPC title

• A61N1/36135

  using physiological parameters · CPC title

• A61B5/026

  Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)} · CPC title

• A61N1/36139

  with automatic adjustment · CPC title